Literature DB >> 11561033

Intensive voice treatment (LSVT) for patients with Parkinson's disease: a 2 year follow up.

L O Ramig1, S Sapir, S Countryman, A A Pawlas, C O'Brien, M Hoehn, L L Thompson.   

Abstract

OBJECTIVES: To assess long term (24 months) effects of the Lee Silverman voice treatment (LSVT), a method designed to improve vocal function in patients with Parkinson's disease.
METHODS: Thirty three patients with idiopathic Parkinson's disease were stratified and randomly assigned to two treatment groups. One group received the LSVT, which emphasises high phonatory-respiratory effort. The other group received respiratory therapy (RET), which emphasises high respiratory effort alone. Patients in both treatment groups sustained vowel phonation, read a passage, and produced a monologue under identical conditions before, immediately after, and 24 months after speech treatment. Change in vocal function was measured by means of acoustic analyses of voice loudness (measured as sound pressure level, or SPL) and inflection in voice fundamental frequency (measured in terms of semitone standard deviation, or STSD).
RESULTS: The LSVT was significantly more effective than the RET in improving (increasing) SPL and STSD immediately post-treatment and maintaining those improvements at 2 year follow up.
CONCLUSIONS: The findings provide evidence for the efficacy of the LSVT as well as the long term maintenance of these effects in the treatment of voice and speech disorders in patients with idiopathic Parkinson's disease.

Entities:  

Mesh:

Year:  2001        PMID: 11561033      PMCID: PMC1763504          DOI: 10.1136/jnnp.71.4.493

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  36 in total

1.  The management of Parkinson's disease.

Authors:  A C ENGLAND; R S SCHWAB
Journal:  Arch Intern Med       Date:  1959-09

2.  Clusters of deviant speech dimensions in the dysarthrias.

Authors:  F L Darley; A E Aronson; J R Brown
Journal:  J Speech Hear Res       Date:  1969-09

3.  Differential diagnostic patterns of dysarthria.

Authors:  F L Darley; A E Aronson; J R Brown
Journal:  J Speech Hear Res       Date:  1969-06

4.  Function of the basal ganglia as revealed by cognitive and motor disorders in Parkinson's disease.

Authors:  C D Marsden
Journal:  Can J Neurol Sci       Date:  1984-02       Impact factor: 2.104

5.  Speech therapy for Parkinson's disease.

Authors:  S Scott; F I Caird
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-02       Impact factor: 10.154

6.  On the role of the anterior cingulate cortex in phonation: a case report.

Authors:  U Jürgens; D von Cramon
Journal:  Brain Lang       Date:  1982-03       Impact factor: 2.381

7.  Cinegraphic observations of laryngeal function in Parkinson's disease.

Authors:  D G Hanson; B R Gerratt; P H Ward
Journal:  Laryngoscope       Date:  1984-03       Impact factor: 3.325

8.  Voice quality changes following phonatory-respiratory effort treatment (LSVT) versus respiratory effort treatment for individuals with Parkinson disease.

Authors:  C A Baumgartner; S Sapir; T O Ramig
Journal:  J Voice       Date:  2001-03       Impact factor: 2.009

9.  Cognitive impairments in Parkinson's disease: distinguishing between effort-demanding and automatic cognitive processes.

Authors:  H Weingartner; S Burns; R Diebel; P A LeWitt
Journal:  Psychiatry Res       Date:  1984-03       Impact factor: 3.222

10.  Frequency and cooccurrence of vocal tract dysfunctions in the speech of a large sample of Parkinson patients.

Authors:  J A Logemann; H B Fisher; B Boshes; E R Blonsky
Journal:  J Speech Hear Disord       Date:  1978-02
View more
  74 in total

1.  Effect of level of presentation to listeners on scaled speech intelligibility of speakers with dysarthria.

Authors:  Yunjung Kim; Christina Kuo
Journal:  Folia Phoniatr Logop       Date:  2012       Impact factor: 0.849

2.  A translational approach to vocalization deficits and neural recovery after behavioral treatment in Parkinson disease.

Authors:  Michelle R Ciucci; Lisa Vinney; Emerald J Wahoske; Nadine P Connor
Journal:  J Commun Disord       Date:  2010-04-08       Impact factor: 2.288

Review 3.  Targeted exercise therapy for voice and swallow in persons with Parkinson's disease.

Authors:  John A Russell; Michelle R Ciucci; Nadine P Connor; Timothy Schallert
Journal:  Brain Res       Date:  2010-03-15       Impact factor: 3.252

4.  Treatment of dysarthria following subthalamic nucleus deep brain stimulation for Parkinson's disease.

Authors:  Elina Tripoliti; Laura Strong; Freya Hickey; Tom Foltynie; Ludvic Zrinzo; Joseph Candelario; Marwan Hariz; Patricia Limousin
Journal:  Mov Disord       Date:  2011-09-27       Impact factor: 10.338

5.  Basic parameters of articulatory movements and acoustics in individuals with Parkinson's disease.

Authors:  Bridget Walsh; Anne Smith
Journal:  Mov Disord       Date:  2012-01-04       Impact factor: 10.338

6.  Exercise Effects on Early Vocal Ultrasonic Communication Dysfunction in a PINK1 Knockout Model of Parkinson's Disease.

Authors:  Cynthia A Kelm-Nelson; Katie M Yang; Michelle R Ciucci
Journal:  J Parkinsons Dis       Date:  2015       Impact factor: 5.568

7.  Speech-related fatigue and fatigability in Parkinson's disease.

Authors:  Matthew J Makashay; Kevin R Cannard; Nancy Pearl Solomon
Journal:  Clin Linguist Phon       Date:  2014-08-25       Impact factor: 1.346

8.  Training BIG to move faster: the application of the speed-amplitude relation as a rehabilitation strategy for people with Parkinson's disease.

Authors:  Becky G Farley; Gail F Koshland
Journal:  Exp Brain Res       Date:  2005-11-11       Impact factor: 1.972

9.  Perceptions of effort during handgrip and tongue elevation in Parkinson's disease.

Authors:  Nancy Pearl Solomon; Donald A Robin
Journal:  Parkinsonism Relat Disord       Date:  2005-09       Impact factor: 4.891

10.  Acoustic evaluation of short-term effects of repetitive transcranial magnetic stimulation on motor aspects of speech in Parkinson's disease.

Authors:  I Eliasova; J Mekyska; M Kostalova; R Marecek; Z Smekal; I Rektorova
Journal:  J Neural Transm (Vienna)       Date:  2012-12-20       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.